 NEW YORK, Dec. 08, 2020 GLOBE NEWSWIRE -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Reata Pharmaceuticals, Inc. NASDAQ: RETA from October 15, 2019 through August 7, 2020, inclusive the Class Period. The lawsuit seeks to recover damages for Reata Pharmaceuticals, Inc. investors under the federal securities laws. 